CEMIX
Price
$10.89
Change
-$0.09 (-0.82%)
Updated
Apr 25 closing price
Net Assets
2.01B
VEMAX
Price
$37.25
Change
-$0.12 (-0.32%)
Updated
Apr 25 closing price
Net Assets
111.75B
Ad is loading...

CEMIX vs VEMAX

Header iconCEMIX vs VEMAX Comparison
Open Charts CEMIX vs VEMAXBanner chart's image
Causeway Emerging Markets Instl
Price$10.89
Change-$0.09 (-0.82%)
VolumeN/A
Net Assets2.01B
Vanguard Emerging Mkts Stock Idx Adm
Price$37.25
Change-$0.12 (-0.32%)
VolumeN/A
Net Assets111.75B
CEMIX vs VEMAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CEMIX vs. VEMAX commentary
Apr 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CEMIX is a Buy and VEMAX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VEMAX has more cash in the bank: 112B vs. CEMIX (2.01B). CEMIX pays higher dividends than VEMAX: CEMIX (3.71) vs VEMAX (3.08). CEMIX was incepted earlier than VEMAX: CEMIX (18 years) vs VEMAX (19 years). CEMIX (1.14) is less costly to investors than VEMAX (0.13). CEMIX is a more actively managed with annual turnover of: 91.00 vs. VEMAX (8.00). VEMAX has a lower initial minimum investment than CEMIX: VEMAX (3000) vs CEMIX (1000000). VEMAX annual gain was more profitable for investors over the last year : 9.23 vs. CEMIX (5.74). VEMAX return over 5 years is better than : 40.41 vs. CEMIX (23.67).
CEMIXVEMAXCEMIX / VEMAX
Total Expense Ratio1.100.13846%
Annual Report Gross Expense Ratio1.140.13877%
Fund Existence18 years19 years-
Gain YTD0.0921.3667%
Front LoadN/AN/A-
Min. Initial Investment1000000300033,333%
Min. Initial Investment IRAN/AN/A-
Net Assets2.01B112B2%
Annual Yield % from dividends3.713.08120%
Returns for 1 year5.749.2362%
Returns for 3 years22.2113.41166%
Returns for 5 years23.6740.4159%
Returns for 10 years7.9318.7642%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MDNAF0.770.03
+4.73%
Medicenna Therapeutics Corp.
UCBJY86.432.27
+2.70%
UCB S.A.
THNPY34.180.85
+2.55%
Technip Energies NV
NVZMY63.910.75
+1.19%
NOVONESIS A S
RHHVF318.07-0.60
-0.19%
Roche Holding Ltd